2011
DOI: 10.5897/ajps11.065
|View full text |Cite
|
Sign up to set email alerts
|

Toxicology of baytril (enrofloxacin)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 0 publications
0
5
0
1
Order By: Relevance
“…In 2010, we isolated the affected chicks(s) at the first clinical sign of a bacterial infection and orally administered 10 mg enrofloxacin/kg of body mass for 7 d. We also treated water with 30 ml/3.78 L of sulfamethoxacole, but found that the bacteria responsible (see results) were resistant to sulfamethoxacole, and discontinued this treatment. In 2011, we instituted a proactive approach by administering the aforementioned dosage of enrofloxacin to all chicks from hatch to 5 d and because enrofloxacin is effective against a majority of the bacteria we encountered [Babaahmady and Khosravi, ]. A negative side effect of enrofloxacin use is its effectiveness against normal gut microflora [Johnson and Nicholson, ].…”
Section: Methodsmentioning
confidence: 99%
“…In 2010, we isolated the affected chicks(s) at the first clinical sign of a bacterial infection and orally administered 10 mg enrofloxacin/kg of body mass for 7 d. We also treated water with 30 ml/3.78 L of sulfamethoxacole, but found that the bacteria responsible (see results) were resistant to sulfamethoxacole, and discontinued this treatment. In 2011, we instituted a proactive approach by administering the aforementioned dosage of enrofloxacin to all chicks from hatch to 5 d and because enrofloxacin is effective against a majority of the bacteria we encountered [Babaahmady and Khosravi, ]. A negative side effect of enrofloxacin use is its effectiveness against normal gut microflora [Johnson and Nicholson, ].…”
Section: Methodsmentioning
confidence: 99%
“…ENRO belongs to the fluoroquinolone class of antibiotics that could inhibit DNA gyrase (topoisomerase II) and topoisomerase IV (topo IV), which are required by bacteria to perform DNA replication. This inhibition produces a cytotoxic effect on the target cells (Babaahmady and Khosravi 2011). Study on resistance genes, susceptibility to antibiotics, and development of resistance to Aeromonas spp.…”
Section: Development Of Resistance By Aeromonas Spp Based On the Mbcs...mentioning
confidence: 99%
“…FQs have been shown to be effective in the treatment against Chlamydia spp., Staphylococcus aureus , E. coli , Salmonella spp., and mycoplasma spp., which usually cause septic arthritis ( Guardabassi, Jensen & Kruse, 2009 ). Enro and Mar were approved for veterinary use for dogs in 1998 ( Babaahmady & Khosravi, 2011 ; Sárközy, 2001 ; Babaahmady & Khosravi, 2011 ; Pallo-Zimmerman, Byron & Graves, 2010 ), respectively. With different substituents at the R-1, R-7, and X-8 positions on the quinolone central ring system, they have a large difference in terms of molecular structure, antibacterial activity, spectrum, and pharmacokinetic properties ( Andriole, 2005 ; Domagala, 1994 ; Farca et al, 2007 ; Hong, Kim & Kim, 1997 ; Pallo-Zimmerman, Byron & Graves, 2010 ; Peterson, 2001 ; Šeol, 2005 ).…”
Section: Introductionmentioning
confidence: 99%